Search for the Structural Basis of Biomacromolecular Function and Activity

NIH Pandemic-Era Grants

Pandemic Era Grants

2022

Document text

Principal Investigator: Yun Xing m wang
Organization: DIVISION OF BASIC SCIENCES - NCI
Fiscal Year: 2022
Award: $2,560,874
Funding agency: National Cancer Institute

My lab has made progress on several fronts. First, we have developed a novel algorithm      and a method using AFM to study RNA conformational dynamics in solution. Briefly, we are now      able to directly visualize individual RNA conformers in solution and determine the structures      of individual RNA molecules; compute the total conformational space of RNA in solution. RNA      molecules are highly dynamic and conformational-heterogeneous. This development is significant      because it makes it possible to characterize individual molecules of heterogeneous      conformations, such as RNA in solution, as opposed to an ensemble of molecules of homogeneous      conformation. We have tested, bench-marked and applied our new approach and method in studying      the RNA structural dynamics and conformational space in a number of important RNA molecules in      solution. These include the HIV packaging signal RNA, Rev response element (RRE) RNA, the      T-box riboswitch with/without tRNA ligand, cobalamine riboswitch RNA w/wo ligand, the 3' and      5'-UTR RNA of the COVID-19 and the RNaseP RNA (both the full-length and core particle). Three      significant manuscripts are either under review or to be submitted. Second, we have      demonstrated the feasibility of using RNA devices to control and regulate the PD-1 gene      expression in mouse EL4 cells. The PD-1 gene is one of the critical genes for cancer      immunotherapy. Thus this project is potentially translational. The basic idea is to use      externally controllable RNA devices that are responsive to ligand bindings. We purposefully      choose an FDA-approved ligand. The devices are engineered in a chromosome of T-cells using the      CRISPR/Cas 9 technique. Built on the progress in the last year, now we have established the      procedure and protocol to quantify the PD-1 expression at various ligand concentrations using      both Western and qPCR methods. We have also obtained information on the kinetic      characteristics of some of the RNA devices in cell. We are currently performing      high-throughput screenings using lenti-libraries with the aim to identify the best RNA devices      that are both of high efficiency and ideal kinetic characteristics in mammalian cells.      Furthermore, we have crystallized one of the RNA devices in both presence and absence of      ligand and thus opened the door for high-resolution structure determination. It is noteworthy      to mention that the structure of any RNA devices has never been determined before. The      high-resolution structure of an RNA may lead us to a better understanding of the      ligand-triggered conformation changes at the atomic level and stimulate new designs of more      efficient RNA devices. Lastly, we have made significant progress in improving the PLOR      technology (Liu et al., Nat. 2015) using high-capacity DNA template attachedbeads. Our aim is      to be able to synthesize kilo-base long mRNA with selectively-labeled or modified residues      placed at desired positions. One of the applications of the improved PLOR could be      manufacturing mRNA selectively labeled with modified pseudo-uridines, as opposed to the      current uniform labelings such as mRNAs in the COVID-19 vaccines by Pfizer or      Moderna.

Terms: <2019-nCoV vaccine><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Algorithms><Atomic Force Microscopy><Biochemical><Biological><Biophysics><COVID-19><COVID-19 vaccine><COVID19><COVID19 vaccine><CRISPR approach><CRISPR based approach><CRISPR method><CRISPR methodology><CRISPR technique><CRISPR technology><CRISPR tools><CRISPR-CAS-9><CRISPR-based method><CRISPR-based technique><CRISPR-based technology><CRISPR-based tool><CRISPR/CAS approach><CRISPR/Cas method><CRISPR/Cas technology><CRISPR/Cas9><CRISPR/Cas9 technology><CV-19><CV19><Cancer Genes><Cancer-Promoting Gene><Cas nuclease technology><Cell Body><Cell Communication and Signaling><Cell Signaling><Cells><Characteristics><Chromosomes><Clustered Regularly Interspaced Short Palindromic Repeats approach><Clustered Regularly Interspaced Short Palindromic Repeats method><Clustered Regularly Interspaced Short Palindromic Repeats methodology><Clustered Regularly Interspaced Short Palindromic Repeats technique><Clustered Regularly Interspaced Short Palindromic Repeats technology><Collaborations><Core Particle><Crystallization><DNA><Deoxyribonucleic Acid><Development><Devices><Engineering><Event><FDA approved><Force Microscopy><Gene Expression><Genes><Goals><HIV><High Throughput Assay><Human Immunodeficiency Viruses><Individual><Intracellular Communication and Signaling><Kinetics><Knowledge><LAV-HTLV-III><Label><Lead><Length><Libraries><Ligand Binding><Ligands><Lymphadenopathy-Associated Virus><Mammalian Cell><Manuscripts><Messenger RNA><Methods><Mice><Mice Mammals><Molecular Configuration><Molecular Conformation><Molecular Stereochemistry><Murine><Mus><NMR Spectrometer><NMR Spectroscopy><Non-Polyadenylated RNA><Nucleic Acids><Nucleosome Core><Nucleosome Core Particle><Oncogenes><PD 1><PD-1><PD1><Pb element><Position><Positioning Attribute><Procedures><Process><Proteins><Protocol><Protocols documentation><RNA><RNA Conformation><RNA Gene Products><Research><Resolution><Response Elements><Ribonucleic Acid><Roentgen Rays><SARS-CoV-2 vaccine><SARS-CoV2 vaccine><SARS-coronavirus-2 vaccine><Scanning Force Microscopy><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe acute respiratory syndrome coronavirus 2 vaccine><Signal Transduction><Signal Transduction Systems><Signaling><Single Crystal Diffraction><Structure><T-Cells><T-Lymphocyte><Techniques><Technology><Testing><Transfer RNA><Transforming Genes><Translational Research><Translational Science><Triplet Codon-Amino Acid Adaptor><UTRs><Untranslated Regions><Urd><Uridine><Virus-HIV><X Ray Crystallographies><X-Radiation><X-Ray Crystallography><X-Ray Diffraction Crystallography><X-Ray Radiation><X-Ray/Neutron Crystallography><X-ray><Xray><Xray Crystallography><anti-cancer immunotherapy><anticancer immunotherapy><base><biologic><biological signal transduction><biomacromolecular><biomacromolecule><biophysical foundation><biophysical principles><biophysical sciences><cancer immunotherapy><conformation><conformational state><conformer><corona virus disease 2019><corona virus disease 2019 vaccine><coronavirus disease 2019><coronavirus disease 2019 vaccine><coronavirus disease-19><coronavirus disease-19 vaccine><coronavirus infectious disease-19><design><designing><developmental><heavy metal Pb><heavy metal lead><high throughput screening><immune-based cancer therapies><immunotherapy for cancer><immunotherapy of cancer><improved><insight><interest><mRNA><new approaches><novel><novel approaches><novel strategies><novel strategy><nuclear magnetic resonance spectroscopy><programmed cell death 1><programmed cell death protein 1><programmed death 1><sle2><systemic lupus erythematosus susceptibility 2><tRNA><thymus derived lymphocyte><transfer Ribonucleic acids><translation research><translational potential><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine for novel coronavirus>